LyRIC indeterminate response and Immune-mediated pseudoprogression of diffuse large B-cell lymphoma following polatuzumab-based salvage therapy

被引：4
|
作者：
Lee, Alexander T. J. [1 ]
Attygale, Ayoma D. [1 ]
Sharma, Rajaei K. [2 ]
Iyengar, Sunil [1 ]
El-Sharkawi, Dima [1 ]
Chau, Ian [1 ]
Vroobel, Katherine M. [1 ]
Fotiadis, Nicos [1 ]
Khan, Nasir [1 ]
Butterfield, Nicholas [1 ]
Wotherspoon, Andrew [1 ]
Cunningham, David [1 ]
Sharma, Bhupinder [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Univ Exeter, Med Sch, Exeter, Devon, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷 / 06期
关键词：
diffuse large B cell lymphoma; polatuzumab; pseudo-progression;
D O I：
10.1111/bjh.16679
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E248 / E251
页数：4
相关论文
共 50 条
  • [1] Pseudoprogression of triple-hit diffuse large B-cell lymphoma following polatuzumab vedotin-based salvage therapy
    Wang, Xin
    McIntosh, Lacey
    Selove, William J.
    Zivny, Jaroslav
    Cerny, Jan
    LEUKEMIA & LYMPHOMA, 2021, 62 (08) : 2022 - 2025
  • [2] Intravascular large B-cell lymphoma treated with polatuzumab-based salvage therapy: A rare case
    Bitar, George
    Wotherspoon, Andrew
    Attygalle, Ayoma D.
    Cunningham, David
    Sharma, Bhupinder
    EJHAEM, 2021, 2 (04): : 887 - 888
  • [3] Time-to-response for patients with relapsed/refractory diffuse large B cell and high grade B cell lymphoma treated with polatuzumab-based therapy
    Landsburg, Daniel J.
    Nasta, Sunita D.
    Gerson, James N.
    Svoboda, Jakub
    Chong, Elise A.
    Schuster, Stephen J.
    Barta, Stefan K.
    Robinson, Kyle W.
    Hughes, Mitchell E.
    LEUKEMIA & LYMPHOMA, 2022, 63 (01) : 243 - 246
  • [4] Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
    Tilly, Herve
    Morschhauser, Franck
    Sehn, Laurie H.
    Friedberg, Jonathan W.
    Trneny, M.
    Sharman, Jeff P.
    Herbaux, Charles
    Burke, John M.
    Matasar, Matthew
    Rai, Shinya
    Izutsu, Koji
    Mehta-Shah, Neha
    Oberic, Lucie
    Chauchet, Adrien
    Jurczak, Wojciech
    Song, Yuqin
    Greil, Richard
    Mykhalska, Larysa
    Bergua-Burgues, Juan M.
    Cheung, Matthew C.
    Pinto, Antonio
    Shin, Ho-Jin
    Hapgood, Greg
    Munhoz, Eduardo
    Abrisqueta, Pau
    Gau, Jyh-Pyng
    Hirata, Jamie
    Jiang, Yanwen
    Yan, Mark
    Lee, Calvin
    Flowers, Christopher R.
    Salles, Gilles
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 351 - 363
  • [5] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma
    Dietliker, N.
    Kiesel, H.
    Mueller, R.
    Mueller, A. M.
    Manz, M.
    Zenz, T.
    Rosler, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 66 - 67
  • [6] Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Sehn, Laurie H.
    Herrera, Alex F.
    Flowers, Christopher R.
    Kamdar, Manali K.
    McMillan, Andrew
    Hertzberg, Mark
    Assouline, Sarit
    Kim, Tae Min
    Kim, Won Seog
    Ozcan, Muhit
    Hirata, Jamie
    Penuel, Elicia
    Paulson, Joseph N.
    Cheng, Ji
    Ku, Grace
    Matasar, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 155 - +
  • [7] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma
    Dietliker, N.
    Kiesel, H.
    Mueller, R.
    Mueller, A. M.
    Manz, M. G.
    Zenz, T.
    Rosler, W.
    SWISS MEDICAL WEEKLY, 2020, : 21S - 21S
  • [8] Polatuzumab Vedotin-Based Salvage Chemotherapy in the Third-Line or Above Treatment for Diffuse Large B-Cell Lymphoma
    Tsai, Cheng-Hong
    Tien, Feng Ming
    Hou, Hsin-An
    Liu, Jia-Hau
    Wu, Shang-Ju
    Wang, Yu-Wen
    Lin, Chien-Chin
    Ko, Bor-Sheng
    Chou, Wen-Chien
    Lin, Yun-Chu
    Cheng, Chieh-Lung
    Lu, Li-Chun
    Kuo, Sung-Hsin
    Hong, Ruey-Long
    Huang, Tai-Chung
    Yao, Ming
    BLOOD, 2020, 136
  • [9] Salvage therapy of diffuse large B cell lymphoma
    Witzens-Harig, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 127 - 127
  • [10] An evaluation of polatuzumab vedotin for the treatment of patients with diffuse large B-cell lymphoma
    Walji, Moneeza
    Assouline, Sarit
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 933 - 942
12345